Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Speculative Buy Bigblu Broadband (BBB) by Edmond Jackson in Interactive Investor
- Buy Persimmon (PSN) by ValueKwik
- Buy Schroders (SDR) by ValueKwik
- Buy Standard Chartered (STAN) by ValueKwik
- Sell MediaZest (MDZ) by Steve Moore in ShareProphets
- Strong Buy Yourgene Health (YGEN) by Tom Winnifrith in Hot Stock Rockets
- Speculative Buy Alba Mineral Resources (ALBA) by Hot Stock Rockets in ShareProphets
- Speculative Buy Altyn (ALTN) by Tom Winnifrith in ShareProphets
- Buy Alliance Pharma (APH) by Roland Head in The Motley Fool
- Buy GlaxoSmithKline (GSK) by Harvey Jones in The Motley Fool
- Buy XLMedia (XLM) by G A Chester in The Motley Fool
- Buy WPP (WPP) by G A Chester in The Motley Fool
- Sell AA (AA.) by Berenberg
- Buy Sanne Group (SNN) by Berenberg
- Sector Perform Morgan Advanced Materials (MGAM) by RBC Capital
- Outperform Amigo Holdings (AMGO) by RBC Capital
- Buy XLMedia (XLM) by Berenberg
- Buy Bovis Homes Group (BVS) by HSBC
- Buy Bellway (BWY) by HSBC
- Avoid SpaceandPeople (SAL) by Steve Moore in ShareProphets
AstraZeneca (AZN)
Health Care Sector
-
Latest quote
6,427.00p (mid)
-
Current Change (%)
0.80%
-
Price
Bid: 6,426.00p
Offer: 6,427.00p
-
Today
High: 6,444.00p
Low: 6,344.00p
-
This year
High: 6,525.00p
Low: 4,760.00p
-
Information
Volume: 842,775
Market Cap: £81430.09M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
| Title | Release date |
|---|---|
| Forxiga approved in Europe for type-1 diabetes | 07:00 - March 25, 2019 |
| US FDA grants saracatinib ODD for IPF | 07:00 - March 18, 2019 |
| Notice of AGM | 12:00 - March 14, 2019 |
| Director/PDMR Shareholding | 12:00 - March 12, 2019 |
| Filing of Form 20-F with SEC | 07:00 - March 6, 2019 |
| Annual Financial Report | 11:00 - March 5, 2019 |
| Holding(s) in Company | 16:04 - March 4, 2019 |
| Total Voting Rights | 15:00 - March 1, 2019 |
| Lynparza receives positive EU CHMP opinion | 13:45 - March 1, 2019 |
| Lynparza significantly delayed disease progression | 07:00 - February 26, 2019 |
| Brilinta's PhIII THEMIS trial met primary endpoint | 07:00 - February 25, 2019 |
| AstraZeneca Full-Year and Q4 2018 Results | 07:00 - February 14, 2019 |
| US FDA grants Fasenra Orphan Drug Designation | 07:00 - February 6, 2019 |
| US FDA grants Breakthrough Therapy Designation | 07:05 - February 5, 2019 |
| EMA grants PRIME eligibility for MEDI8897 | 07:00 - February 5, 2019 |
NOTE: This is based on 204 open tips for this company
